The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 08, 2025

Filed:

Feb. 11, 2022
Applicant:

Enclear Therapies, Inc., Newburyport, MA (US);

Inventors:

Anthony DePasqua, Newburyport, MA (US);

Kevin Eggan, Jr., Boston, MA (US);

Kevin Kalish, Newburyport, MA (US);

Manual A. Navia, Lexington, MA (US);

Kasper Roet, Somerville, MA (US);

Ching-Hua Tseng, Belmont, MA (US);

Alan D. Watson, Lexington, MA (US);

William X. Siopes, Lowell, MA (US);

Gianna N. Riccardi, South Berwick, ME (US);

Marcie Ann Glicksman, Salem, MA (US);

Assignee:

EnClear Therapies, Inc., Newburyport, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/36 (2006.01); A61M 1/16 (2006.01); A61M 27/00 (2006.01);
U.S. Cl.
CPC ...
A61M 1/3687 (2013.01); A61M 1/16 (2013.01); A61M 1/1601 (2014.02); A61M 27/006 (2013.01); A61M 1/3655 (2013.01); A61M 1/3659 (2014.02); A61M 2027/004 (2013.01); A61M 2202/0464 (2013.01); A61M 2205/103 (2013.01); A61M 2205/12 (2013.01); A61M 2205/3334 (2013.01); A61M 2205/3344 (2013.01); A61M 2205/3379 (2013.01); A61M 2210/1003 (2013.01); A61M 2210/1039 (2013.01);
Abstract

Cerebrospinal fluid (CSF) and other fluid amelioration systems completely or partially implantable within a mammalian subject and associated methods include a substrate and an agent for amelioration of a toxic biomolecule present in the CSF or fluid, wherein the agent is disposed on or within the substrate.


Find Patent Forward Citations

Loading…